γ-Catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of β-catenin

β-Catenin and γ-catenin (plakoglobin), vertebrate homologs of Drosophila armadillo, function in cell adhesion and the Wnt signaling pathway. In colon and other cancers, mutations in the APC tumor suppressor protein orβ-catenin's amino terminus stabilizeβ-catenin, enhancing its ability to activate transcription of Tcf/Lef target genes. Thoughβ- and γ-catenin have analogous structures and functions and like binding to APC, evidence that γ-catenin has an important role in cancer has been lacking. We report here that APC regulates bothβ- and γ-catenin andγ-catenin functions as an oncogene. In contrast to β-catenin, for which only amino-terminal mutated forms transform RK3E epithelial cells, wild-type and several amino-terminal mutated forms of γ-catenin had similar transforming activity. γ-Catenin's transforming activity, like β-catenin's, was dependent on Tcf/Lef function. However, in contrast toβ-catenin, γ-catenin strongly activated c-Myc expression and c-Myc function was crucial for γ-catenin transformation. Our findings suggest APC mutations alter regulation of bothβ- and γ-catenin, perhaps explaining why the frequency of APC mutations in colon cancer far exceeds that of β-catenin mutations. Elevated c-Myc expression in cancers with APC defects may be due to altered regulation of both β- andγ-catenin. Furthermore, the data implyβ- and γ-catenin may have distinct roles in Wnt signaling and cancer via differential effects on downstream target genes.

[1]  A. Millar,et al.  Beta-catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway. , 1999, Cancer research.

[2]  M. Bienz APC: the plot thickens. , 1999, Current opinion in genetics & development.

[3]  L. Larue,et al.  Lack of beta-catenin affects mouse development at gastrulation. , 1995, Development.

[4]  P. Polakis,et al.  Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Hans Clevers,et al.  XTcf-3 Transcription Factor Mediates β-Catenin-Induced Axis Formation in Xenopus Embryos , 1996, Cell.

[6]  Michael Kühl,et al.  Functional interaction of β-catenin with the transcription factor LEF-1 , 1996, Nature.

[7]  B. Herrmann,et al.  Nuclear localization of β-catenin by interaction with transcription factor LEF-1 , 1996, Mechanisms of Development.

[8]  E. Fuchs,et al.  De Novo Hair Follicle Morphogenesis and Hair Tumors in Mice Expressing a Truncated β-Catenin in Skin , 1998, Cell.

[9]  S. Hirohashi,et al.  Beta-catenin mutation in carcinoma of the uterine endometrium. , 1998, Cancer research.

[10]  J. Palacios,et al.  β-Catenin Expression Pattern in Stage I and II Ovarian Carcinomas : Relationship with β-Catenin Gene Mutations, Clinicopathological Features, and Clinical Outcome , 1999 .

[11]  L. Larue,et al.  Lack of beta-catenin affects mouse development at gastrulation. , 1995, Development.

[12]  T. Maniatis,et al.  A ubiquitin ligase complex essential for the NF-kappaB, Wnt/Wingless, and Hedgehog signaling pathways. , 1999, Genes & development.

[13]  Y. Nakamura,et al.  Activation of the beta-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3. , 1998, Cancer research.

[14]  P. Cohen,et al.  PDK1, one of the missing links in insulin signal transduction? 1 , 1997, FEBS letters.

[15]  Satoshi Ikeda,et al.  Axin Directly Interacts with Plakoglobin and Regulates Its Stability* , 1999, The Journal of Biological Chemistry.

[16]  P. Cohen,et al.  Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling. , 1993, The Biochemical journal.

[17]  M. Buendia,et al.  Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[18]  E. Wieschaus,et al.  A Drosophila homolog of the tumor suppressor gene adenomatous polyposis coli down-regulates beta-catenin but its zygotic expression is not essential for the regulation of Armadillo. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Rudolf Grosschedl,et al.  Modulation of Transcriptional Regulation by LEF-1 in Response to Wnt-1 Signaling and Association with β-Catenin , 1998, Molecular and Cellular Biology.

[20]  Paul Polakis,et al.  The oncogenic activation of β-catenin , 1999 .

[21]  Paul Polakis,et al.  Stabilization of β-Catenin by Genetic Defects in Melanoma Cell Lines , 1997, Science.

[22]  K. Kinzler,et al.  Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC−/− Colon Carcinoma , 1997, Science.

[23]  M. Kirschner,et al.  Control of beta-catenin stability: reconstitution of the cytoplasmic steps of the wnt pathway in Xenopus egg extracts. , 2000, Molecular cell.

[24]  T. Akiyama,et al.  Down-regulation of β-Catenin by the Colorectal Tumor Suppressor APC Requires Association with Axin and β-Catenin* , 2000, The Journal of Biological Chemistry.

[25]  D L Rimm,et al.  Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer. , 1999, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[26]  Benjamin Geiger,et al.  Differential Nuclear Translocation and Transactivation Potential of β-Catenin and Plakoglobin , 1998, The Journal of cell biology.

[27]  H. Schwarz,et al.  Desmosomal localization of beta-catenin in the skin of plakoglobin null-mutant mice. , 1999, Development.

[28]  C. Raffel,et al.  Sporadic Medulloblastomas Contain Oncogenic β-Catenin Mutations , 1998 .

[29]  B. Geiger,et al.  Suppression of tumorigenicity by plakoglobin: an augmenting effect of N- cadherin , 1996, The Journal of cell biology.

[30]  Yusuke Nakamura,et al.  AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1 , 2000, Nature Genetics.

[31]  W. Birchmeier,et al.  E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton , 1994, The Journal of cell biology.

[32]  M. Peifer,et al.  The segment polarity gene armadillo encodes a functionally modular protein that is the Drosophila homolog of human plakoglobin , 1990, Cell.

[33]  O. MacDougald,et al.  Glycogen Synthase Kinase 3 Is an Insulin-Regulated C/EBPα Kinase , 1999, Molecular and Cellular Biology.

[34]  Bert Vogelstein,et al.  Mutational Analysis of the APC/β-Catenin/Tcf Pathway in Colorectal Cancer , 1998 .

[35]  R. Benarous,et al.  The F-box protein β-TrCP associates with phosphorylated β-catenin and regulates its activity in the cell , 1999, Current Biology.

[36]  H. Clevers,et al.  Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1. , 1999, Science.

[37]  W. Birchmeier,et al.  Targeted mutation of plakoglobin in mice reveals essential functions of desmosomes in the embryonic heart , 1996, The Journal of cell biology.

[38]  Hans Clevers,et al.  Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC , 1997, Science.

[39]  K. Kinzler,et al.  Lessons from Hereditary Colorectal Cancer , 1996, Cell.

[40]  B. Geiger,et al.  Differential molecular interactions of beta-catenin and plakoglobin in adhesion, signaling and cancer. , 1998, Current opinion in cell biology.

[41]  S. Hirohashi,et al.  Association of plakoglobin with APC, a tumor suppressor gene product, and its regulation by tyrosine phosphorylation. , 1994, Biochemical and biophysical research communications.

[42]  R. Koski,et al.  Distribution of cells expressing myc proteins in human colorectal epithelium, polyps, and malignant tumors. , 1992, Cancer research.

[43]  R. Nusse,et al.  Wnt signaling: a common theme in animal development. , 1997, Genes & development.

[44]  Paul Polakis,et al.  The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors , 1999, Oncogene.

[45]  E. Wieschaus,et al.  The segment polarity gene armadillo interacts with the wingless signaling pathway in both embryonic and adult pattern formation. , 1991, Development.

[46]  M. Kitagawa,et al.  An F‐box protein, FWD1, mediates ubiquitin‐dependent proteolysis of β‐catenin , 1999, The EMBO journal.

[47]  K. Kinzler,et al.  Apoptosis and APC in colorectal tumorigenesis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[48]  R. Nusse,et al.  β-catenin: a key mediator of Wnt signaling , 1998 .

[49]  M. Peifer,et al.  Wnt signaling in oncogenesis and embryogenesis--a look outside the nucleus. , 2000, Science.

[50]  P. Soballe,et al.  Mutations in beta-catenin are uncommon in colorectal cancer occurring in occasional replication error-positive tumors. , 1997, Cancer research.

[51]  C. Albanese,et al.  The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[52]  S. Albrecht,et al.  Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene. , 1999, Cancer research.

[53]  C. Dang,et al.  Neoplastic Transformation of RK3E by Mutant β-Catenin Requires Deregulation of Tcf/Lef Transcription but Not Activation of c-myc Expression , 1999, Molecular and Cellular Biology.

[54]  Stephen J. Elledge,et al.  The SCFβ-TRCP–ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IκBα and β-catenin and stimulates IκBα ubiquitination in vitro , 1999 .

[55]  D. Rimm,et al.  Frequent nuclear/cytoplasmic localization of beta-catenin without exon 3 mutations in malignant melanoma. , 1999, The American journal of pathology.

[56]  D. Rimm,et al.  Frequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinoma. , 1999, Cancer research.

[57]  J. K. Scott,et al.  The c-myc protein is constitutively expressed at elevated levels in colorectal carcinoma cell lines. , 1988, Oncogene.

[58]  E. Gelmann,et al.  β-Catenin Mutations in Human Prostate Cancer , 1998 .

[59]  Y. Nakamura,et al.  Activation of the beta-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations. , 1998, Cancer research.

[60]  A. Sparks,et al.  Identification of c-MYC as a target of the APC pathway. , 1998, Science.

[61]  H. Schwarz,et al.  Desmosomal localization of β-catenin in the skin of plakoglobin null -mutant mice , 1998 .

[62]  P. Polakis,et al.  The APC Protein and E-cadherin Form Similar but Independent Complexes with α-Catenin, β-Catenin, and Plakoglobin (*) , 1995, The Journal of Biological Chemistry.

[63]  S. H. Lee,et al.  Frequent somatic mutations of the beta-catenin gene in intestinal-type gastric cancer. , 1999, Cancer research.

[64]  M. Taketo,et al.  Intestinal polyposis in mice with a dominant stable mutation of the β‐catenin gene , 1999, The EMBO journal.

[65]  W. Nelson,et al.  Cadherins, catenins and APC protein: interplay between cytoskeletal complexes and signaling pathways. , 1997, Current opinion in cell biology.

[66]  猪股雅史 Alteration of β-catenin expression in colonic epithelial cells of familial adenomatous polyposis patients(家族性大腸腺腫症患者の大腸上皮細胞における細胞間接着分子β-カテニンの発現変化) , 1997 .

[67]  K. Kinzler,et al.  Association of the APC tumor suppressor protein with catenins. , 1993, Science.

[68]  K. Kinzler,et al.  PPARδ Is an APC-Regulated Target of Nonsteroidal Anti-Inflammatory Drugs , 1999, Cell.

[69]  F. van Roy,et al.  Beta-catenin mutations are more frequent in small colorectal adenomas than in larger adenomas and invasive carcinomas. , 1999, Cancer research.

[70]  Frank McCormick,et al.  β-Catenin regulates expression of cyclin D1 in colon carcinoma cells , 1999, Nature.